![Anne E. Goodbody](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anne E.
Goodbody is Vice President of Drug Development for Vasogen, Inc. Dr. Goodbody has 20 years of experience in research and development in the biopharmaceutical industry.
She held various positions at Allelix, Inc., Resolution Pharmaceuticals, Bayer and Molecular Insight Pharmaceuticals, Inc. Dr. Goodbody received a graduate degree in Biochemistry from the University of Aberdeen and a PhD from the University of Cambridge, UK.
| Sociétés | Poste | Fin |
|---|---|---|
Vasogen, Inc.
 Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Corporate Officer/Principal | 23/10/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Health Technology |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
